1. AB0541 Factors associated with selection of rituximab vs alternative TNF inhibitor (TNFI) following TNFI failure in patients with rheumatoid arthritis: Sub-analysis of switch-RA, a global, comparative effectiveness observational study. (23rd January 2014) Authors: Gottenberg, J.-E.; Mpofu, C.; Bensen, W.; Rubbert-Roth, A.; Irazoque, F.; Martínez Taboada, V.; Chung, C.; Hinsch-Gylvin, L.; Ferri, C.; Emery, P. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 669 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0173 Gastrointestinal perforations with certolizumab PEGOL. (23rd January 2014) Authors: Fleischmann, R.; Rubbert-Roth, A.; Combe, B.; VanLunen, B.; Andrews, P.; de Longueville, M. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 370 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0256 Long-term safety of tocilizumab in patients with rheumatoid arthritis following a mean treatment duration of 3.9 years. (23rd January 2014) Authors: Genovese, M.; Sebba, A.; Rubbert-Roth, A.; Scali, J.; Alten, R.; Kremer, J.; Pitts, L.; Vernon, E.; van Vollenhoven, R. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A461 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0316 The Efficacy and Safety of Subcutaneous Tocilizumab versus Intravenous Tocilizumab in Combination with Traditional DMARDS in Patients with RA at Week 97 (SUMMACTA). (10th June 2014) Authors: Burmester, G.; Rubbert-Roth, A.; Cantagrel, A.; Hall, S.; Leszczynski, P.; Feldman, D.; Rangaraj, M.J.; Roane, G.; Ludivico, C.; Mysler, E.; Bennett, M.J.; Rowell, L.; Bao, M. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FRI0394 The Proteasome Inhibitor Bortezomib Ameliorates Refractory Systemic Lupus Erythematosus (SLE): A Prospective Multi-Centre Observational Study. (10th June 2014) Authors: Alexander, T.; Sarfert, R.; Klotsche, J.; Rubbert-Roth, A.; Lorenz, H.-M.; Rech, J.; Hoyer, B.; Cheng, Q.; Waka, A.; Taddeo, A.; Kühl, A.A.; Schett, G.; Burmester, G.-R.; Radbruch, A.; Hiepe, F.; Voll, R.E. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 530 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OP0041 Tocilizumab (TCZ) in Combination and Monotherapy Versus Methotrexate (MTX) in MTX-Naive Patients (PTS) with Early Rheumatoid Arthritis (RA): Clinical and Radiographic Outcomes from a Randomised, Placebo-Controlled Trial. (23rd January 2014) Authors: Burmester, G.; Rigby, W.; van Vollenhoven, R.; Kay, J.; Rubbert-Roth, A.; Kelman, A.; Dimonaco, S.; Mitchell, N. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SAT0105 Summacta: A Randomized, Double-Blind, Parallel Group Study of the Safety and Efficacy Of Tocilizumab SC Versus Tocilizumab IV, in Combination with Traditional Dmards in Patients With Moderate to Severe Ra. (23rd January 2014) Authors: Burmester, G. R.; Rubbert-Roth, A.; Cantagrel, A.; Hall, S.; Leszczynski, P.; Feldman, D.; Rangaraj, M. J.; Roane, G.; Ludivico, C.; Mysler, E.; Rowell, L.; Vranic, I. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗